Literature DB >> 8807033

Zolpidem-induced psychosis.

J S Markowitz1, T D Brewerton.   

Abstract

Zolpidem is reported to be a safe and effective hypnotic agent for the short-term treatment of insomnia. There are several case reports of zolpidem causing psychotic reactions in patients with no history of psychosis. We report two additional cases in which zolpidem was implicated in psychotic reactions characterized by auditory and visual hallucinations as well as delusional thinking. Both patient's symptoms resolved with the discontinuation of zolpidem use. It appears that our cases share several features in common with the other reported cases. All were female, there appeared to be some dose dependency involved, and the adverse event resolved fairly quickly upon zolpidem discontinuation. Zolpidem should be used at the lowest effective dose for the least amount of time as necessary. Female patients may possibly require smaller doses. In patients manifesting new-onset or unexplained psychotic symptoms, zolpidem use should be considered in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807033     DOI: 10.3109/10401239609148806

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  13 in total

1.  Adverse reactions to zolpidem: case reports and a review of the literature.

Authors:  Takuji Inagaki; Tsuyoshi Miyaoka; Seiichi Tsuji; Yasushi Inami; Akira Nishida; Jun Horiguchi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  New-onset transient hallucinations possibly due to eszopiclone: a case study.

Authors:  Harpreet S Duggal
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 3.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  New-Onset Visual Hallucinations With Eszopiclone.

Authors:  J Michael McGuire; Meghan Duquette; Steven M Burghart; Michael J Ferri
Journal:  Prim Care Companion CNS Disord       Date:  2016-04-14

Review 5.  New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.

Authors:  Mario Giovanni Terzano; Mariano Rossi; Vincenzo Palomba; Arianna Smerieri; Liborio Parrino
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Two cases of zolpidem-associated homicide.

Authors:  Cheryl M Paradis; Lawrence A Siegel; Stuart B Kleinman
Journal:  Prim Care Companion CNS Disord       Date:  2012-08-23

7.  A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: a pilot study.

Authors:  Stephanie C Licata; David M Penetar; Steven Dunlap; Scott E Lukas
Journal:  Eur J Pharmacol       Date:  2008-09-22       Impact factor: 4.432

8.  A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T.

Authors:  Stephanie C Licata; J Eric Jensen; David M Penetar; Andrew P Prescot; Scott E Lukas; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2009-01-06       Impact factor: 4.530

Review 9.  Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

Authors:  Christian Dolder; Michael Nelson; Jonathan McKinsey
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.

Authors:  Tuan M Tran; Joseph Browning; Mary L Dell
Journal:  Malar J       Date:  2006-08-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.